Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Brainstorm Cell Therapeutics Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +1 vs. Q4 2023
- Shares held
- 4.04M
- +82.4K (+2.1%) vs. Q4 2023
- Total value
- $2.19M
- +$1.15M (+111.0%) vs. Q4 2023
- New holders
- 7
- 5 more added
- Sold out
- 6
- 10 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCLI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 5 | $1.73K |
| Q2 2025 | 34 | $264.0K |
| Q1 2025 | 32 | $1.09M |
| Q4 2024 | 34 | $560.3K |
| Q3 2024 | 38 | $2.52M |
| Q2 2024 | 48 | $4.09M |
| Q1 2024 | 47 | $2.19M |
| Q4 2023 | 46 | $1.04M |
| Q3 2023 | 53 | $928.4K |
| Q2 2023 | 57 | $11.5M |
| Q1 2023 | 48 | $20.4M |
| Q4 2022 | 43 | $6.16M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 48 | $11.0M |
| Q1 2022 | 39 | $14.0M |
| Q4 2021 | 42 | $17.6M |
| Q3 2021 | 52 | $16.9M |
| Q2 2021 | 57 | $21.4M |
| Q1 2021 | 75 | $32.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Brainstorm Cell Therapeutics Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,400,993 | $791.1K | 0.00% | −22,317−1.6% | Reduced |
| BlackRock Inc. | 489,313 | $276.3K | 0.00% | +22,958+4.9% | Added |
| Geode Capital Management, LLC | 357,041 | $201.7K | 0.00% | 00.0% | Unchanged |
| Liberty Wealth Management LLC | 340,150 | $192.0K | 0.04% | 00.0% | Unchanged |
| Weaver Consulting Group | 199,356 | $112.6K | 0.04% | 00.0% | Unchanged |
| Abner Herrman & Brock LLC | 145,500 | $82.0K | 0.01% | 00.0% | Unchanged |
| Raymond James & Associates | 113,785 | $64.3K | 0.00% | −2,000−1.7% | Reduced |
| Gsa Capital Partners LLP | 111,234 | $63.0K | 0.01% | +111,234 | New |
| State Street Corp | 96,060 | $54.2K | 0.00% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 90,242 | $51.0K | 0.01% | 00.0% | Unchanged |
| Kingswood Wealth Advisors, LLC | 81,050 | $45.8K | 0.01% | +81,050 | New |
| Jmac Enterprises LLC | 65,430 | $36.9K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 54,788 | $30.9K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 40,098 | $22.6K | 0.00% | −11,353−22.1% | Reduced |
| Group One Trading, L.P. | 30,654 | $17.3K | 0.00% | +6,611+27.5% | Added |
| Wells Fargo & Company | 29,110 | $16.4K | 0.00% | −772−2.6% | Reduced |
| Susquehanna International Group, LLP | 26,544 | $15.0K | 0.00% | +1,713+6.9% | Added |
| Creative Planning | 21,726 | $12.3K | 0.00% | +710+3.4% | Added |
| Janney Montgomery Scott LLC | 20,500 | $12.0K | 0.00% | 00.0% | Unchanged |
| Saxony Capital Management, LLC | 20,950 | $11.8K | 0.01% | −200−0.9% | Reduced |
| Jane Street Group, LLC | 18,732 | $10.6K | 0.00% | +18,732 | New |
| Professional Financial Advisors, LLC | 17,279 | $9.76K | 0.00% | 00.0% | Unchanged |
| First Affirmative Financial Network | 15,278 | $8.63K | 0.01% | −425−2.7% | Reduced |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 12,686 | $7.16K | 0.00% | 00.0% | Unchanged |
| Socha Financial Group, LLC | 12,380 | $6.99K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 11,994 | $6.77K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 11,005 | $6.22K | 0.00% | −7,231−39.7% | Reduced |
| Advisor Group Holdings, Inc. | 10,519 | $5.89K | 0.00% | −220−2.0% | Reduced |
| Cypress Capital Management LLC (WY) | 10,000 | $5.65K | 0.01% | 00.0% | Unchanged |
| Institutional & Family Asset Management, LLC | 6,000 | $3.39K | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 4,200 | $2.37K | 0.00% | 00.0% | Unchanged |
| Bangor Savings Bank | 4,000 | $2.26K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 4,039 | $2.00K | 0.00% | +4,039 | New |
| UBS Group AG | 2,500 | $1.41K | 0.00% | 00.0% | Unchanged |
| VisionPoint Advisory Group, LLC | 1,944 | $1.10K | 0.00% | 00.0% | Unchanged |
| Clearstead Advisors, LLC | 1,500 | $822 | 0.00% | +1,500 | New |
| EverSource Wealth Advisors, LLC | 2,128 | $803 | 0.00% | 00.0% | Unchanged |
| Cranbrook Wealth Management, LLC | 1,000 | $565 | 0.00% | +1,000 | New |
| Bank of America Corp | 1,000 | $564 | 0.00% | −54−5.1% | Reduced |
| St Germain D J Co Inc | 500 | $282 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 364 | $206 | 0.00% | 00.0% | Unchanged |
| Westside Investment Management, Inc. | 200 | $112 | 0.00% | 00.0% | Unchanged |
| CoreCap Advisors, LLC | 133 | $75 | 0.00% | +133 | New |
| JPMorgan Chase & Co | 106 | $60 | 0.00% | +35+49.3% | Added |
| Mark Sheptoff Financial Planning, LLC | 100 | $56 | 0.00% | 00.0% | Unchanged |
| Caldwell Sutter Capital, Inc. | 157,009 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 317 | $0 | 0.00% | −227−41.7% | Reduced |
| Virtu Financial LLC | 0 | $0 | 0.00% | −70,986−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −23,128−100.0% | Sold out |
| Zullo Investment Group, Inc. | 0 | $0 | 0.00% | −16,114−100.0% | Sold out |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −10,250−100.0% | Sold out |
| Able Wealth Management LLC | 0 | $0 | 0.00% | −1,920−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −127−100.0% | Sold out |